IntegriChain delivers the life science industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
From the first launch to ongoing market access execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We are the data and application backbone for market access departments of Life Sciences manufacturers, enabling them to accelerate their commercialization process, digitalize their operations, and get therapies to patients faster.
Solutions overview
To ensure you get the most out of your access and commercialization investment, IntegriChain provides a complete set of professional Advisory and Systems Integration Services designed to further your business and success.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, Market Access experts, analysts, technologies, and advisory professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Keep in touch with IntegrChain through our news and frequent events.
View all news & events
Originally Broadcast April 15, 2019; Available Now for Replay
Join us for the first in a series of webinars focused on Access Launch Readiness. We’ll start this series with our new daVIZta colleagues for a great entry point for emerging Life Sciences manufacturers who are planning their launch within the next two years.
Moderator: Jennifer Sharpe, Executive Advisor, Revenue Analytics Collaborative Presenter: Jeff Baab, Executive Director, Professional Services
Jeff Baab and Jen Sharpe will share their thought leadership and experience with payer coverage and policy trends that will affect your go to market Payer strategy and downstream Gross-to-Net impacts. During the webinar, we’ll:
